These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36238028)

  • 1. [A New Healthcare Policy in Korea Part 1: Expanded Reimbursement Coverage of Brain MRI, Brain/Neck MRA, and Head and Neck MRI by National Health Insurance].
    Kim E
    Taehan Yongsang Uihakhoe Chi; 2020 Sep; 81(5):1053-1068. PubMed ID: 36238028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Consideration of National Health Insurance Reform for Universal Health Coverage in the Republic of Korea.
    Lee Y; Kim S; Kim SY; Kim G
    Asian Bioeth Rev; 2019 Mar; 11(1):41-56. PubMed ID: 33717299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [National Health Insurance System of Korea: Resource-Based Relative Value Scale and a New Healthcare Policy].
    Choi JI
    Taehan Yongsang Uihakhoe Chi; 2020 Sep; 81(5):1024-1037. PubMed ID: 36238039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation.
    Lee SS; Salole E
    Value Health; 2014 Jun; 17(4):476-81. PubMed ID: 24969010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A New Healthcare Policy in Korea Part 3: Ultrasound and MRI in Urogenital Disorders].
    Shim YS; Park KJ
    Taehan Yongsang Uihakhoe Chi; 2020 Sep; 81(5):1083-1095. PubMed ID: 36238042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A New Health Care Policy in Korea Part 2: Expansion of Coverage by National Health Insurance on the Abdominal Ultrasound and MRI].
    Jang MJ; Park SJ
    Taehan Yongsang Uihakhoe Chi; 2020 Sep; 81(5):1069-1082. PubMed ID: 36238023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.
    Shih YR; Liao KH; Chen YH; Lin FJ; Hsiao FY
    Clin Transl Sci; 2020 Sep; 13(5):916-922. PubMed ID: 32166908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of expanding health insurance coverage for anti-cancer drugs on cancer survival in Korea.
    Cho DY; Park J; Kim DS
    Cancer Med; 2021 Jul; 10(13):4555-4563. PubMed ID: 34145980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Korean medicine coverage in the National Health Insurance in Korea: present situation and critical issues.
    Lim B
    Integr Med Res; 2013 Sep; 2(3):81-88. PubMed ID: 28664058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How public and private health insurance coverage mitigates catastrophic health expenditures in Republic of Korea.
    Jung HW; Kwon YD; Noh JW
    BMC Health Serv Res; 2022 Aug; 22(1):1042. PubMed ID: 35971176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of positron emission tomography.
    Digby W; Keppler J
    Radiol Manage; 2000; 22(1):37-40. PubMed ID: 10787760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea.
    Rayzah M; Ryu JM; Lee JH; Nam SJ; Kim SW; Lee SK; Yu J; Lee KT; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    J Korean Med Sci; 2021 Jul; 36(29):e194. PubMed ID: 34313035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.
    Koo JS; Moon SH; Lee H; Park S; Yu YM; Kang HY
    PLoS One; 2020; 15(12):e0244759. PubMed ID: 33382798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in imaging utilization for acute ischemic stroke based on patient insurance status.
    Brinjikji W; El-Sayed AM; Rabinstein AA; McDonald JS; Cloft HJ
    AJR Am J Roentgenol; 2014 Aug; 203(2):372-6. PubMed ID: 25055273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The process of National Health Insurance coverage for Chuna Manual Therapy in Korea: A qualitative study.
    Yu J; Shin BC; Kim H; Hyun E; Lee JH; Kim MR; Lim B
    Integr Med Res; 2022 Mar; 11(1):100746. PubMed ID: 34277346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.
    Liao KH; Ko BS; Chen LK; Hsiao FY
    Clin Transl Sci; 2020 Nov; 13(6):1288-1297. PubMed ID: 32583962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs.
    Takayama A; Narukawa M
    Ther Innov Regul Sci; 2016 May; 50(3):361-367. PubMed ID: 30227073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Effectiveness of Intravenous Thrombolysis for Acute Ischemic Stroke Outside the Coverage of National Health Insurance in Taiwan.
    Su YH; Chen CH; Lin HJ; Chen YW; Tseng MC; Hsieh HC; Chen CH; Sung SF
    Acta Neurol Taiwan; 2017 Mar; 26(1):3-12. PubMed ID: 28752508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the National Health Insurance improved the inequality in the use of tertiary-care hospitals in Korea?
    Kim S; Kwon S
    Health Policy; 2014 Dec; 118(3):377-85. PubMed ID: 25459734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of National Health Insurance Coverage on Compliance With Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea.
    Choi W; Bae M; Chung Y
    Clin Exp Otorhinolaryngol; 2022 Feb; 15(1):100-106. PubMed ID: 33561916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.